Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EUROPE RESEARCH ROUNDUP-Carnival, Michelin, William Demant

Fri, 23rd Mar 2018 07:06

March 23 (Reuters) - Securities analysts revised their ratings and price targets on severalEuropean companies, including Carnival, Michelin and William Demant, on Friday. HIGHLIGHTS * Carnival Plc : Barclays raises to overweight from equal weight * E.ON SE : RBC raises to outperform from sector perform * Michelin : Morgan Stanley cuts to equal weight from overweight * William Demant : Morgan Stanley cuts to underweight from equal-weightFollowing is a summary of research actions on European companies reported by Reuters on Friday.Stock entries are in alphabetical order. * Altice NV : Barclays cuts target price to EUR 11 from EUR 11.10 * AstraZeneca Plc : Jefferies?? cuts price target to 5500p * Barclays Plc : RBC raises price target to 220p from 215p?? * Bayer AG : Jefferies cuts price target to 118 euros?? * BBVA : Jefferies cuts target price to EUR 7.30 from EUR 7.70 * Bpost SA : RBC cuts target price to EUR 20 from EUR 24.50 * Carnival Plc : Barclays raises to overweight from equal weight * Centrica Plc : Credit Suisse raises price target to 175p from 170p?? * Conzzeta AG : Credit Suisse raises target price to SFR 1400 from SFR 1300 * E.ON SE : RBC raises target price to EUR 10.25 from EUR 10 * E.ON SE : RBC raises to outperform from sector perform * Elekta AB : Morgan Stanley raises price target to SEK 82 from SEK 73?? * Gamma Communications Plc : RBC raises target price to 675p from 650p * GlaxoSmithKline Plc : Jefferies cuts price target to 1450p?? * HSBC Holdings Plc : RBC cuts price target to 730p from 750p?? * Innogy SE : RBC raises target price to EUR 37 from EUR 34 * Man Group Plc : Barclays cuts target price to 180p from 185p * Michelin : Morgan Stanley cuts to equal weight from overweight * Michelin : Morgan Stanley cuts price target to 125 euros from 135 euros?? * Moncler : RBC raises target price to EUR 33 from EUR 28 * Novo Nordisk : Jefferies cuts price target to DKK 315?? * Roche Holding AG : Jefferies cuts price target to SFR 285?? * Sabre Insurance Group Plc : Barclays cuts target price to 302p from 312p * Standard Chartered Plc : RBC raises price target to 700p from 695p?? * William Demant : Morgan Stanley cuts to underweight from equal-weight * William Demant : Morgan Stanley raises target price to DKK 208 from DKK 177 (Compiled by Bengaluru Newsroom)
More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.